These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9182350)

  • 21. Health-related quality of life of patients with implantable cardioverter defibrillators compared with that of pacemaker recipients.
    Leosdottir M; Sigurdsson E; Reimarsdottir G; Gottskalksson G; Torfason B; Vigfusdottir M; Eggertsson S; Arnar DO
    Europace; 2006 Mar; 8(3):168-74. PubMed ID: 16627433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heart-to-heart partnerships cut costs of cardiac products.
    Doyle FF; Donahue RE
    Mater Manag Health Care; 1997 Apr; 6(4):18, 20. PubMed ID: 10166585
    [No Abstract]   [Full Text] [Related]  

  • 23. A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death.
    Tung R; Zimetbaum P; Josephson ME
    J Am Coll Cardiol; 2008 Sep; 52(14):1111-21. PubMed ID: 18804736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cost of implantable defibrillators: perceptions and reality.
    Camm J; Klein H; Nisam S
    Eur Heart J; 2007 Feb; 28(4):392-7. PubMed ID: 16887857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ICD: a qualitative study of patient experience the first year after implantation.
    Kamphuis HC; Verhoeven NW; Leeuw R; Derksen R; Hauer RN; Winnubst JA
    J Clin Nurs; 2004 Nov; 13(8):1008-16. PubMed ID: 15533107
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Defibrillators in heart failure and quality of life.
    Matlock DD
    N Engl J Med; 2009 Jan; 360(2):187-8; author reply 189. PubMed ID: 19129534
    [No Abstract]   [Full Text] [Related]  

  • 27. Lifetime cost-effectiveness of prophylactic implantation of a cardioverter defibrillator in patients with reduced left ventricular systolic function: results of Markov modelling in a European population.
    Cowie MR; Marshall D; Drummond M; Ferko N; Maschio M; Ekman M; de Roy L; Heidbuchel H; Verboven Y; Braunschweig F; Linde C; Boriani G
    Europace; 2009 Jun; 11(6):716-26. PubMed ID: 19359333
    [TBL] [Abstract][Full Text] [Related]  

  • 28. What's the difference between a pacemaker and an implantable cardioverter defibrillator (ICD)?
    Johns Hopkins Med Lett Health After 50; 2001 Nov; 13(9):8. PubMed ID: 11682906
    [No Abstract]   [Full Text] [Related]  

  • 29. Quality of life and psychological status of patients with implantable cardioverter defibrillators.
    Thomas SA; Friedmann E; Kao CW; Inguito P; Metcalf M; Kelley FJ; Gottlieb SS
    Am J Crit Care; 2006 Jul; 15(4):389-98. PubMed ID: 16823016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Efficiency potential in the pacemaker/implantable cardioverter defibrillator outpatient clinic].
    Bauer A; Bauer J; Bauer M; Kelemen K; Voss F; Senges-Becker J; Weretka S; Katus HA; Becker R
    Herzschrittmacherther Elektrophysiol; 2006 Mar; 17(1):26-34. PubMed ID: 16547657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transvenous implantable cardioverter-defibrillator leads: the weakest link.
    Maisel WH
    Circulation; 2007 May; 115(19):2461-3. PubMed ID: 17502585
    [No Abstract]   [Full Text] [Related]  

  • 32. Care of the pacemaker/implantable cardioverter defibrillator patient in the ED.
    McMullan J; Valento M; Attari M; Venkat A
    Am J Emerg Med; 2007 Sep; 25(7):812-22. PubMed ID: 17870488
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-effectiveness of ICDs.
    Fauchier L; Babuty D
    N Engl J Med; 2006 Jan; 354(2):205-7; author reply 205-7. PubMed ID: 16411302
    [No Abstract]   [Full Text] [Related]  

  • 34. Benefits of the implantable cardioverter-defibrillator.
    Epstein AE
    J Am Coll Cardiol; 2008 Sep; 52(14):1122-7. PubMed ID: 18804737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microvolt T-wave alternans and the selective use of implantable cardioverter defibrillators for primary prevention: a cost-effectiveness study.
    Filion KB; Xie X; van der Avoort CJ; Dendukuri N; Brophy JM
    Int J Technol Assess Health Care; 2009 Apr; 25(2):151-60. PubMed ID: 19331707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Implantable cardioverter-defibrillators.
    Mack MJ
    N Engl J Med; 2005 May; 352(19):2022-5; author reply 2022-5. PubMed ID: 15888706
    [No Abstract]   [Full Text] [Related]  

  • 37. [Current indications for cardioverter-defibrillator implant in patients with syncope].
    Santini M; Colivicchi F; Ammirati F; Ricci R
    Cardiologia; 1999 Dec; 44 Suppl 1(Pt 2):575-9. PubMed ID: 12497786
    [No Abstract]   [Full Text] [Related]  

  • 38. Cost-effectiveness of ICDs.
    Anderson KP
    N Engl J Med; 2006 Jan; 354(2):205-7; author reply 205-7. PubMed ID: 16407520
    [No Abstract]   [Full Text] [Related]  

  • 39. Cost effectiveness of the implantable cardioverter defibrillator.
    Roberts PR; Betts TR; Morgan JM
    Eur Heart J; 2000 May; 21(9):712-9. PubMed ID: 10739726
    [No Abstract]   [Full Text] [Related]  

  • 40. Cost-Effectiveness Related to Implantable Electronic Cardiac Devices: An Ever-Constant Concern.
    Camanho LEM
    Arq Bras Cardiol; 2024 Apr; 121(4):e20240185. PubMed ID: 38716991
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.